<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941202-0-00036</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (v) Patient or human research subject followup; or  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 45. In &sect;35.930, the section heading and paragraphs (a)(1) and (a)(2) are revised and paragraphs (a)(3) and (a)(4) are added to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.930 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for therapeutic use of unsealed byproduct material.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) *&blank;*&blank;*  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) The American Board of Nuclear Medicine;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) The American Board of Radiology in radiology, therapeutic radiology, or radiation oncology;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) Nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (4) The American Osteopathic Board of Radiology after 1984; or  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 46. In &sect;35.940, paragraph (a)(1) is revised to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.940 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for use of brachytherapy sources.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) *&blank;*&blank;*  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) Radiology, therapeutic radiology, or radiation oncology by the American Board of Radiology;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 47. In &sect;35.950, paragraphs (a)(1) and (a)(2) are revised and paragraph (a)(4) is added to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.950 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for use of sealed sources for diagnosis.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) *&blank;*&blank;*  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) Radiology, diagnostic radiology, therapeutic radiology, or radiation oncology by the American Board of Radiology;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) Nuclear medicine by the American Board of Nuclear Medicine;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (4) Nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 48. In &sect;35.960, paragraphs (a)(1) and (b)(3)(iii) are revised to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.960 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for teletherapy.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) *&blank;*&blank;*  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) Radiology, therapeutic radiology, or radiation oncology by the American Board of Radiology;  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (b) *&blank;*&blank;*  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) *&blank;*&blank;*  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iii) Calculating the teletherapy doses and collaborating with the authorized user in the review of patients' or human research subjects' progress and consideration of the need to modify originally prescribed doses as warranted by patients' or human research subjects' reaction to radiation; and  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 49. In &sect;35.961, paragraph (b) is redesignated as paragraph (c) and a new paragraph (b) is added to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.961 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Training for teletherapy physicist.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (b) Is certified by the American Board of Medical Physics in radiation oncology physics; or  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * *  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 50. Section 35.972 is revised to read as follows:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;35.972 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Recentness of training.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The training and experience specified in this subpart must have been  <!-- PJG 0012 frnewline --> obtained within the 7 years preceding the date of application or the  <!-- PJG 0012 frnewline --> individual must have had related continuing education and experience since the required training and experience was completed.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            